Dr Reddy’s Rises After US FDA Nod for Cancer Biosimilar
Dr Reddy’s Laboratories touched a day high of ₹1,182 after the company disclosed in an exchange filing that it received US FDA approval. The approval...
Tag : Dr Reddy’s
Sensex Sinks 637 Points, Gives Up 61,00, Nifty Near 18,000, Realty, Metals Lead Losses
Stocks fell under selling pressure on Wednesday, snapping a two-day winning streak, as Wall Street awaited the release of minutes from the latest Federal Reserve...
Sensex And Nifty50 Widen Their Gap on Back of Financials, IT And FMCG Stocks
India’s stock market benchmark rose for the first time on Thursday after it began tracking strength in global markets, as investors ignored price pressures cited...
Dr Reddy’s Lowers Price of Sputnik Booster
Dr Reddy’s lab said on May 19 that it would reduce the price of the Sputnik Light vaccine, which will be used as a booster...
Dr Reddy’s gets EIR for Medak units from USFDA
Dr Reddy’s Laboratories has received Establishment Inspection Report (EIR) for the company’s Medak units, from the US health regulator. The company stated the exchanges that, it has...
Dr Reddy’s Q4 net profit down 3.3% YoY
Dr Reddy’s Laboratories net profit slumps 3.3% YoY to Rs.302.2 crore, for the quarter ended March 31,2018. The company in the same quarter last year,...
Dr Reddy’s launches Palonosetron Hydrochloride Injection in US
Dr Reddy’s Laboratories Limited has launched Palonosetron Hydrochloride Injection, 0.25 mg/ml in US. It has been approved by the US Food and Drug Administration (USFDA) and...
Dr Reddy’s receives USFDA approval for Sapropterin Dihydrochloride
Dr Reddy’s Laboratories has received approval from the US health regulator for drug that reduces blood phenylalanine concentrations in patients. It has received tentative approval from...
Dr Reddy’s receives EIR for Bachupally unit from USFDA
Dr Reddy’s Laboratories has received an establishment inspection report (EIR) for Bachupally unit, Hyderabad, after the closure of its audit from the US Food and Drug...
Dr Reddy’s receives EIR for Telangana unit, from USFDA
Dr Reddy’s Laboratories has received Establishment Inspection Report (EIR), for its Miyapur facility, Hyderabad, Telangana. The Custom Pharmaceutical Services facility, of Dr Reddy’s Laboratories at the...